BrightGene Bio-Medical Technology Co., Ltd.

XSSC:688166 Stock Report

Market Cap: CN¥12.8b

BrightGene Bio-Medical Technology Management

Management criteria checks 3/4

BrightGene Bio-Medical Technology's CEO is Jiandong Yuan, appointed in Jan 2021, has a tenure of 3.83 years. directly owns 32.24% of the company’s shares, worth CN¥4.13B. The average tenure of the management team and the board of directors is 6.5 years and 4.3 years respectively.

Key information

Jiandong Yuan

Chief executive officer

CN¥1.9m

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownership32.2%
Management average tenure6.5yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Jiandong Yuan (54 yo)

3.8yrs

Tenure

CN¥1,912,700

Compensation

Mr. Jiandong Yuan serves as the Chairman and General Manager of BrightGene Bio-Medical Technology Co., Ltd. (Formerly known as Borui Biopharmaceutical (Suzhou) Co., Ltd.) since 2021 and is its Director sin...

Leadership Team

NamePositionTenureCompensationOwnership
Jiandong Yuan
Chairman & GM3.8yrsCN¥1.91m32.24%
CN¥ 4.1b
Yuanlai Zou
Chief Financial Officer9.3yrsCN¥436.60kno data
Nan Ding
Board Secretary3.2yrsCN¥441.50kno data
Kai Li
Deputy General Manager9.3yrsCN¥974.60kno data
Fang Liu
Accounting Supervisorno datano datano data

6.5yrs

Average Tenure

50.5yo

Average Age

Experienced Management: 688166's management team is seasoned and experienced (6.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jiandong Yuan
Chairman & GM9.3yrsCN¥1.91m32.24%
CN¥ 4.1b
Lei Su
Director3.2yrsno datano data
Xing He
Chairman of the Supervisory Board4.5yrsno datano data
Yingxian Shen
Supervisor7.2yrsno datano data
Wei Cha
Supervisor3.2yrsno datano data
Jingfu He
Employee Representative Supervisor4.3yrsno datano data
Zijun Zhang
Employee Representative Supervisor3.2yrsno datano data

4.3yrs

Average Tenure

39yo

Average Age

Experienced Board: 688166's board of directors are considered experienced (4.3 years average tenure).